Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score<sup>®</sup> Test?

Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score<sup>®</sup> Test?

The aim of this study was to combine breast MRI-derived biomarkers with clinical-pathological parameters to identify patients who truly need an Oncotype DX Breast Recurrence Score<sup>®</sup> (ODXRS) genomic assay, currently used to predict the benefit of adjuvant chemotherapy in ER-posi...

Full description

Bibliographic Details
Main Authors: Francesca Galati, Valentina Magri, Giuliana Moffa, Veronica Rizzo, Andrea Botticelli, Enrico Cortesi, Federica Pediconi
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Diagnostics
Subjects:
early breast cancer
multiparametric MRI
MRI biomarkers
oncotype DX recurrence score
genomic assays
adjuvant therapy
Online Access:https://www.mdpi.com/2075-4418/12/11/2730

Internet

https://www.mdpi.com/2075-4418/12/11/2730

Similar Items